GenSight will attend the 2nd Annual Gene Therapy for Rare Disorders Europe on October 23-24, 2018 in London, UK and will give two oral presentations.

Oral presentation:  Supporting Clinical Development in the Gene Therapy Space Through Biodistribution & Immunogenicity Assessment

  • Oral presenter: Céline Bouquet, Preclinical Manager
  • Date & Time:  Tuesday 23 October, 12.00 – 12.30 PM
  • Topic Title:  Defining & Executing Robust Clincal Development Strategies


Oral presentation:  Managing Late-Stage Gene Therapy Development in Preparation for MA/BLA Applications

  • Oral presenter: Isabelle Pengué Koyi, VP, Regulatory Affairs & Quality
  • Date & Time:  Wednesday 24 October, 3.45-4.15 PM
  • Topic Title:  Navigating the Complex European Regulatory Landscape